The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

Response to Bee Venom Acupuncture and Polymorphism of Interleukin 4 Receptor and Interleukin 10 in Rheumatoid Arthritis

  • Kim, Yung-Tae (Research Group of Pain and Neuroscience) ;
  • Lee, Jae-Dong (East-West Medical Research Institute, Kyung Hee University) ;
  • Lee, Yun-Ho (Department of Acupuncture & Moxibustion, College of Oriental Medicine Kyung Hee University)
  • Published : 2004.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : We investigated to find the relationship between single-nucleotide polymorphism (SNP) of IL4R, IL-10 and bee venom therapy efficacy in patients with RA treated with bee venom for 8 weeks. Methods : Korean RA patients (n=114) and healthy subjects (n=109) were included in this prospective study. Korean bee venom was dissolved in saline (diluted 1:3000) and administrated into acupuncture points. Bee venom therapy was applied twice a week and continued for 8 weeks. The clinical response was evaluated using various assessments before and after treatment. Disease severity was measured by determining the number of tender joints and swollen joints. Laboratory studies included ESR, CRP, and rheumatoid factor. Genotyping for IL-4R and IL-10 polymorphism was done by pyrosequencing analysis. Results : 1. In IL4R genotypes, there was significant difference between RA ptitients tind controls group. 2. In IL4R genotypes, there was significant difference among Good, Mild and Bad responders to in RA patients, but in the frequency of alleles and carriers, there were no significant difference. 3. There was no significant difference between RA patients and controls group in IL-10 gene genotypes. 4. In IL-10 genotypes, there was no significant difference among Good, Mild and Bad responders to in RA patients. 5. There was no significant difference in the improvement of ESR, CRP and KHAQ scores after bee venom therapy in RA patients among the IL4R or IL-10 genotypes. Conclusions : In IL-4R genotypes, there was significant difference between RA patients and control group, and among Good, Mild and Bad responders in RA patients. However, in IL-10 genotypes, there was no significant difference between RA patients and controls group and among Good, Mild and Bad responders in RA patients.

Keywords

References

  1. Biochem. Pharmacol. v.31 Effect of honeybee (Apis mellifera) venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat Eiseman JL;von Bredow J;Alvares AP
  2. J. Rheumatol. v.11 Bee venom and adjuvant induced disease Hadjipetrou-Kourounakis L;Yiangou M
  3. Chemistry and pharmacology of honey bee venom Barbara Rudolf
  4. Venomous Animals and their Venoms v.3 Chemistry, pharmacology and toxicology of bee, wasp and hornet venoms Habermann E.
  5. J Vet Med Sci. v.63 no.3 Bee venom pretreatment has both an antinociceptive and anti-inflammatory effect on carrageenan- induced inflammation Lee JH;Kwon YB;Han HJ;Mar WC;Lee HJ;Yang IS;Beitz AJ;Kang SK
  6. Rheum Dis Clin North Am. v.24 IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis Keystone E;Wherry J;Grint P
  7. J Investig Med. v.47 Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo Woods JM;Tokuhira M;Berry JC(et al.)
  8. Am J Hum Genet. v.72 no.6 Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos Bugawan TL;Mirel DB;Valdes AM;Panelo A;Pozzilli P;Erlich HA
  9. Diabetes v.51 no.11 Association of IL4R haplotypes with type 1 diabetes Mirel DB;Valdes AM;Lazzeroni LC;Reynolds RL;Erlich HA;Noble JA
  10. Rheum Dis Clin North Am. v.25 no.4 Venoms, copper, and zinc in the treatment of arthritis Caldwell JR
  11. J of Korean acupuncture & Moxibution society v.17 no.4 A study on major components of bee venom using HPLC Lee JS;Kwon GR;Choi HY
  12. J Soc Gynecol Investig. v.10 no.1 Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing Wieser F;Fabjani G;Tempfer C;Schneeberger C;Sator M;Huber J;Wenzl R
  13. Hum Genet. v.110 no.5 Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing Gruber JD;Colligan PB;Wolford JK
  14. Biochem Biophys Res Commun. v.309 no.2 Quantification of single nucleotide polymorphisms by automated DNA sequencing Qiu P;J Soder G;Sanfiorenzo VJ;Wang L;R Greene J;Fritz MA;Cai XY
  15. Genomics. v.82 no.3 Molecular haplotype determination using allele-specific PCR and pyrosequencing technology Pettersson M;Bylund M;Alderborn A
  16. Anal Biochem. v.317 no.2 Single-nucleotide polymorphism detection in plants using a single-stranded pyrosequencing protocol with a universal biotinylated primer Pacey-Miller T;Henry R
  17. Life Sci. v.71 no.2 The water-soluble fraction of bee venom produces antinoceiceptive and anti-inflammatory effects on rheumatoid arthritis in rats Kwon YB;Lee HJ;Han HJ;Mar WC;Kang SK;Yoon OB;Beitz AJ;Lee JH
  18. Pain v.90 no.3 Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses Kwon YB;Lee JD;Lee HJ;Han HJ;Mar WC;Kang SK;Beitz AJ;Lee JH
  19. J of Korean acupuncture & Moxibution society v.10 no.1 Study on the acupuncture, moxibustion and herbal-acupuncture with gentianae macrophyllae radix extract solution upon the adjuvant arthritis in rats Kim JG;Lee YH;Park DS
  20. N Engl J Med. v.343 Infliximab and methotrexate in the treatment of rheumatoid arthritis Lipsky PE;van der Heijde DM;St Clair EW(et al.)
  21. Ann Rheum Dis. v.59 no.Suppl.1 Biological role of interleukin 1 receptor antagonist isoforms Arend WP;Guthridge CJ
  22. Semin Arthritis Rheum. v.26 Cytokine inhibitors in autoimmune disease Weckmann AL;Alcocer-Varela J
  23. Rheumatology (Oxford) v.42 no.1 Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations MacKay K;Milicic A;Lee D;Tikly M;Laval S;Shatford J;Wordsworth P
  24. Am J Hum Genet. v.70 no.1 Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma Howard TD;Koppelman GH;Xu J;Zheng SL;Postma DS;Meyers DA;Bleecker ER
  25. Arthritis Rheum. v.33 Low levels of interleukin 4 and high levels of transforming growth factor $\beta$<\TEX> in rheumatoid synovitis Miossec P;Navilliat M;Dupuy d' Angeac A;Sany J;Banchereau J
  26. Arthritis Rheum. v.37 Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis Miossec P;Chomarat P;Dechanet J;Moreau J-F;Roux J-P;Delmas P(et al.)
  27. Genes Immun. v.1 Cytokine gene polymorphism in human disease: on-line databases Bidwell J;Keen L;Gallagher G;Kimberly R;Huizinga T;McDermott M(et al.)
  28. New Engl J Med. v.337 The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor Hershey GK;Friedrich MF;Esswein LA;Thomas ML;Chatila TA
  29. J Exp Med. v.174 Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes de Waal Malefyt R;Abrams J;Bennett B;Figdor CG;de Vries JE
  30. Proc Natl Acad Sci. v.89 Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes Rousset F;Garcia E;Defrance T(et al.)
  31. J Exp Med. v.179 Immunoregulatory role of interleukin 10 in rheumatoid arthritis Katsikis PD;Chu CQ;Brennan FM;Maini RN;Feldmann M
  32. Immunogenetics v.46 Mapping of the human IL-10 gene and further characterization of the 5' flanking sequence Eskdale J;Kube D;Tesch H;Gallagher G
  33. Arthritis Rheum. v.42 Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Crawley E;Kay R;Sillibourne J;Patel P;Hutchinson I;Woo P
  34. Rheumatology v.39 Are differences in interleukin 10 productiassociated with joint damage? Huizinga TW;Keijsers V;Yanni G(et al.)
  35. Genes Immun. v.1 Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus Eskdale J;Keijsers V;Huizinga T;Gallagher G
  36. Genes Immun. v.1 New polymorphisms in the IL-10 promoter region D' Alfonso S;Rampi M;Rolando V;Giordano M;Momigliano-Richiardi P
  37. Eur J Immunogenet v.24 An investigation of polymorphism in the interleukin-10 gene promoter Turner DM;Williams DM;Sankaran D;Lazarus M;Sinnott PJ;Hutchinson IV
  38. Am J Pharmacogenomics v.3 no.3 Approaches to identifying genetic predictors of clinical outcome in rheumatoid arthritis Barton A;John S
  39. Ann Rheum Dis. v.62 no.6 Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis Padyukov L;Lampa J;Heimburger M;Ernestam S;Cederholm T;Lundkvist I;Andersson P;Hermansson Y; Harju A;Klareskog L;Bratt J